• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.30 0.30
(0.00%)
Sensex
83,442.50 9.61
( 0.01%)
Bank Nifty
56,949.20 -82.70
( -0.15%)
Nifty IT
38,866.95 -299.60
( -0.76%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,585.13 -225.75
(-0.57%)
Nikkei 225
8,806.53 -16.38
(-0.19%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
37.7078673
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
11.16
22.31
EPS(TTM)
Face Value()
Div & Yield %
4.66
10
0
 

Shree Salasar Investments reports consolidated net profit of Rs 1.34 crore in the December 2024 quarter
Feb 15,2025
Net profit of Shree Salasar Investments reported to Rs 1.34 crore in the quarter ended December 2024. There were no net profit/loss reported during the previous quarter ended December 2023. Sales rose 498.03% to Rs 12.14 crore in the quarter ended December 2024 as against Rs 2.03 crore during the previous quarter ended December 2023.

ParticularsQuarter Ended
Dec. 2024Dec. 2023% Var.
Sales12.142.03 498
OPM %14.509.85 -
PBDT1.750.06 2817
PBT1.750.06 2817
NP1.340 0